|
|
||||||||
J Thorac Cardiovasc Surg 1998;116:327-331
© 1998 Mosby, Inc.
Cardiopulmonary Support and Physiology |
From the Department of Cardiothoracic and Vascular Surgery, Johann-Wolfgang-Goethe University (Chairman: Peter Satter, MD, Professor of Surgery), Frankfurt, Germany.
Received for publication August 26, 1997. Revisions requested Nov. 3, 1997; revisions received March 10, 1998. Accepted for publication March 25, 1998. Address for reprints: Kai Ihnken, MD, Stanford University Hospital, Department of Surgery, Room H3680, 300 Pasteur Dr., Stanford, CA 94305.
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
Oxygen-derived free radicals and nitric oxide (NO)-derived peroxinitrite play an important role in the development of hyperoxic damage.
5,6 This assumption is partly based on the beneficial effect of treatment with oxygen-derived free radical scavengers
7,8 and by direct evidence of increased levels of oxygen-derived free radicals during reoxygenation.
9 The rate of production of these highly reactive toxic oxygen species is dependent on the oxygen level during reoxygenation and on cellular oxygen metabolism.
10,11 In their early studies, Hearse, Humphrey, and Bullock
12 could demonstrate that lowering PO2 during reoxygenation was followed by less release of myocardial creatine kinase.
12 Further investigations found similar results in organs other than the heart.
11,13 We
14 introduced the concept of normoxic CPB in hypoxemic immature hearts to avoid myocardial damage after hyperoxia. The present clinical study of normoxic adult hearts supported by CPB tests the hypothesis that reduction of oxygen concentration in the circuit of the extracorporeal circulation to normoxic levels can reduce the damaging effects of hyperoxia and will result in an improved postoperative myocardial status.
| Patients and methods |
|---|
|
|
|---|
CPB and myocardial protection.
After induction of general anesthesia and systemic application of heparin (300 IU/kg body weight), CPB (Stöckert Instrumente, München, Germany) was initiated in a standard fashion. Moderate body hypothermia (28° to 32° C) was used. The coronary sinus was cannulated (Research Medical Inc., Salt Lake City, Utah) and antegrade/retrograde blood cardioplegic arrest was used in all patients as described elsewhere.
15 One group of patients underwent hyperoxic CPB (PO2 = 400 mm Hg) (normal clinical practice) and the other group underwent normoxic CPB (PO2 = 140 mm Hg). Arterial oxygen levels were measured by means of an in-line oxygen determination device (Extracorporeal Blood Gas Monitoring System 300, Cardiovascular Devices Inc., Irvine, Calif.). Other than the oxygen content during CPB, the patient management was the same for both groups. After the patients had been rewarmed to a core temperature of at least 35° C, CPB was discontinued and protamine given for heparin reversal.
Blood samples and measurements.
Samples of coronary sinus blood (for determination of polymorphonuclear leukocyte [PMN] elastase, creatine kinase, lactic dehydrogenase, antioxidant levels, malondialdehyde, nitrate, and glucose) and systemic venous blood (for lactate, pH, PO2, and PCO2) were taken at the beginning and at the end of CPB. PMN elastase was measured by means of an immunoassay (Merck, Darmstadt, Germany). Creatine kinase, lactic dehydrogenase, lactate, and glucose determinations were done by means of test kits (Boehringer Mannheim GmbH, Mannheim, Germany). Blood antioxidant status was determined according to the method of Miller and colleagues.
16 This test measures the total plasma antioxidant activity without differentiating between individual contribution of plasma antioxidants (i.e., ascorbate, protein thiols, bilirubin, urate, and
-tocopherol).
16 Malondialdehyde was determined by the method described by Wong and coauthors.
17 Nitrate was measured after reduction to nitrite as described by Green and colleagues.
18
Cardiopulmonary measurements.
A Swan-Ganz pulmonary artery catheter (Baxter Healthcare Corp., Edwards Division, Santa Ana, Calif.) was inserted for measurement of pulmonary artery and pulmonary capillary wedge pressure and for measurement of cardiac output. Hemodynamic measurements were made before starting the surgical procedure and after skin closure. Cardiac index (L/min/m2) is cardiac output (L/min) divided by body surface area (m2). Pulmonary vascular resistance index (PVRI) was calculated by means of the following equation: PVRI (mm Hg x min x L-1 x kg) = (PAP LAP) (mm Hg) x CO-1 (ml/min) x BW (kg), where PAP is pulmonary artery pressure, LAP is left atrial pressure, CO is cardiac output, and BW is body weight.
Pulmonary function tests were done 1 day before and 5 days after the operation. Measurements included vital capacity, forced vital capacity, forced expiratory volume in the first second, and maximum expiratory flow at 50% vital capacity. The results are given as percent of normal values, corrected for sex, age, and body surface area.
Statistical analysis.
Statistical analysis was done in cooperation with the Statistical Department of the Albert-Ludwigs-University Freiburg, Germany. Data were analyzed with StatView V2.0 on an Apple Macintosh IICi computer. Analysis of variance was used for overall comparison. Differences between individual groups were evaluated by t test and Scheffe F test. The end-CPB values were used unless stated otherwise. The paired two-tailed Student's t test was used for comparison of repeatedly documented variables within experimental groups. Group data are expressed as mean ± standard deviation.
| Results |
|---|
|
|
|---|
|
|
|
|
|
|
|
Systemic venous levels of lactate, pH, PO2, and PCO2 at the end of CPB showed no difference between groups. The absolute values are shown in Table II.
|
|
Maximal expiratory flow also was reduced in patients undergoing hyperoxic CPB (p = 0.0001 vs before CPB) and displayed no changes in normoxic patients (p = 0.8 and p = 0.003 vs hyperoxic patients). The absolute values are displayed in Table III.
|
| Discussion |
|---|
|
|
|---|
A widely known example of the damaging effect of hyperoxia is retrolental fibroplasia in premature infants treated with high oxygen levels during ventilator support.
19 Previous studies of the hypoxic immature heart suggested the existence of the damaging potential of high oxygen levels during extracorporeal circulation.
1,2,14 Support for these findings stems from clinical studies of cyanotic children with tetralogy of Fallot having lipid peroxidation after the start of CPB.
3 Additionally, there is evidence of myocardial dysfunction in infants in whom extracorporeal membrane oxygenation is used, despite absence of surgical ischemia.
4 Despite the known damaging potential of high oxygen levels, CPB is commonly constituted in a hyperoxic fashion. And although several adverse effects of CPB (i.e., complement activation, release of PMN elastase and tumor necrosis factor, oxygen-derived free radical production) have already been addressed, the influence of hyperoxia during extracorporeal circulation has yet to be established.
20,21 CPB itself can lead to the production of damaging oxygen-derived free radicals.
20 Highly cytotoxic reduced oxygen species (O2-, H2O2 and
OH) play a central part in oxygen-mediated injury.
5 During normal metabolism, the cell protects itself from these products by ubiquitous endogenous free radical scavengers, which may be depleted by severe stress (hypoxia, ischemia). Thereafter, the burst of free radical production that occurs with the onset of reoxygenation or hyperoxia overwhelms the scavenging capacity of the reduced cellular defense system.
22 Support for this observation stems from direct evidence of these toxic oxygen species with spin trapping and by avoiding oxygenation injury with antioxidants.
9,22 We
8,23 confirmed these observations recently by showing a positive effect of cardioplegic enrichment, or prime supplementation with antioxidants to reduce reoxygenation injury in hypoxic immature piglet hearts.
Instead of treatment with antioxidants, it is conceivable that oxygen-derived free radicals can be avoided by lowering PO2 during extracorporeal circulation. The production of toxic oxygen species is proportionate to PO2.
7,11,24 Hyperoxemia sharply elevates the amount of oxygen dissolved in the membrane lipid matrix, thereby enhancing the possibility of oxygen interaction with reduced electron carriers and accentuating free radical production.
24 In an experimental animal model without CPB, Hearse, Humphrey, and Bullock
12 have shown that myocardial damage that occurs with reoxygenation is highly depended on PO2 and that lowering oxygen levels will result in reduced creatine kinase release. It is conceivable that the reoxygenation injury becomes exaggerated when hypoxic myocardium is exposed abruptly to high PO2, as occurs when CPB is started.
1 Similar to these observations, the results of the present study suggest the existence of an oxygenation injury in normoxic adult hearts on CPB. Compared with the start of CPB, there was a significant increase in PMN elastase, creatine kinase, lactic dehydrogenase, and malondialdehyde, as well as reduced antioxidants at the end of the extracorporeal circulation. In contrast, applying normoxic CPB resulted in a significant improvement within these parameters. It is speculated that further reduction of PO2 during CPB (100 mm Hg) will lead to further improvement in results. This hypothesis is based on the observation that reoxygenation injury is reducible by controlling oxygen levels in CPB prime and blood cardioplegic solutions to 100 mm Hg, to apply normoxia during the initial reoxygenation period.
14 Furthermore, for the first time, we described a new method of "controlled reoxygenation" in which CPB is started with ambient PO2 (30 mm Hg) and normoxic reoxygenation is begun at the time of cardioplegic arrest.
25 Applying this method, we were able to avoid biochemical evidence of reoxygenation injury and to present almost complete functional recovery in previously hypoxic hearts.
2 These findings and the results of the current study reinforce the hypothesis that oxygenation injury is dependent on PO2 and confirm the salutary effect of avoiding hyperoxia.
A second pathway of oxidant injury was proposed by Beckman and associates,
6 whereby superoxide anion and NO interact to form cytotoxic oxygen species. Furthermore, NO generation is dependent on PO2 level.
26 In cyanotic immature hearts we demonstrated a burst of NO at the onset of CPB associated with oxidant damage and myocardial dysfunction, which could be ameliorated by NO inhibition.
27 Additionally, lowering oxygen levels in the circuit of the extracorporeal circulation and in blood cardioplegic solution limited NO release.
25 In the present study, controlling the rate of introduction of molecular oxygen at the start of CPB reduced NO levels when compared with unchanged high values after hyperoxia. It is speculated that excess NO reacts with oxygen and generates OONO-, which then decomposes to generate highly toxic 02 and N2 intermediates that produce lipid peroxidation. As in previous studies, reduced NO levels were accompanied by impaired malondialdehyde (lipid peroxidation), reduced creatine kinase release, and preserved antioxidant reserve capacity.
2,14,25 However, the role of NO in cardiac oxygenation injury on CPB has to be addressed further. The present clinical study was purely observational and was not undertaken to investigate underlying mechanisms, as is the aim of basic research.
The synergism of damage related to oxygen-derived free radicals and neutrophil elastase has been reported.
28 We measured PMN elastase, which was elevated after hyperoxic CPB, supporting former reports in which, however, PO2 levels during CPB are not mentioned.
21 On the contrary, normoxic CPB resulted in a significantly impaired increase of PMN elastase, which was accompanied by less lipid peroxidation and preserved antioxidant levels. To our knowledge, this is the first time that a PO2-dependent elastase release on CPB is described. Oxygen-dependent reduction of lipid peroxidation in this investigation confirms our previous findings, as well as those of others.
2,7,11,14,22,23,27
No significant difference between groups was found in post-CPB contractility. However, cardiac performance was measured at one low point of the Starling function curve. It is speculated that applying more sensitive methods (conductance catheter) or measuring cardiac performance at different preload levels (Starling curves) may reveal impaired function after hyperoxic CPB. This hypothesis is based on our previous studies, in which severely damaged hearts after reoxygenation injury could be weaned from CPB without inotropic support and had a normal cardiac output at low filling pressures. However, measuring contractility with conductance catheter or increasing stress by augmenting preload suggested a severely impaired cardiac performance.
1,2 In contrast, after normoxic or controlled reoxygenation, these same measurements indicated complete ventricular recovery.
14,25
We acknowledge that the results of the present study are inconclusive in terms of cardiac performance. However, even though short-term benefits of normoxic CPB may not be immediately obvious, long-term changes of lipid peroxidation and free radical damage is currently unknown and will have to be studied. However, there is no rationale to expose patients to an obvious biochemical injury whose long-term effect is yet to be determined and which easily can be avoided by applying more physiologic methods. We look to further clinical studies using the described methods to prove whether biochemical oxygenation injury in normoxic adult hearts after hyperoxic CPB is accompanied by a relevant loss in performance.
Impaired lung function in patients undergoing hyperoxic CPB indicates that hyperoxia is not damaging to the heart alone but rather has a whole body effect, a theory that is supported by other reports.
13,29 Leukocyte-originated oxygen free radicalrelated lipid peroxidation with subsequent lung injury after CPB has been reported; unfortunately the PO2 during CPB was not mentioned.
29 Leukocyte depletion resulted in less injury.
29 This finding supports our observation that reduced leukocyte-derived PMN elastase was associated with less lipid peroxidation and creatine kinase release. Again, further studies will clarify the effect of hyperoxia during CPB on organs other than the heart.
Our former findings of a reoxygenation injury in cyanotic immature hearts on hyperoxic CPB are supported by the present clinical study, which for the first time investigates the oxidative challenge of hyperoxia during cardiac operations in adults, comparing it with a normoxic management.
30 Former findings of the damaging effect of CPB may be, at least in part, more related to hyperoxia than to CPB itself. We found convincing evidence that reduced PO2 during CPB is crucial in avoiding oxygen-derived free radical damage and lipid peroxidation. Hyperoxia is not physiologic, it is damaging to all organs, and it is not required during extracorporeal circulation, where oxygen delivery can be adjusted easily by augmenting pump flow. The safety of normoxic CPB is confirmed by measurement of venous lactate, pH, PO2, and PCO2, showing no differences between groups. It is suggested that, contrary to conventional practice, CPB in hypoxic immature hearts as well as in normoxic adult hearts is instituted in a normoxic fashion to avoid oxygenation damage and lipid peroxidation.
We thank Dr. Olschewski, of the statistical department of the Albert-Ludwigs-University Freiburg, for helping with the statistical analysis.
| Footnotes |
|---|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
E. M. Carvalho, E. A Gabriel, and T. A Salerno Pulmonary Protection During Cardiac Surgery: Systematic Literature Review Asian Cardiovasc Thorac Ann, December 1, 2008; 16(6): 503 - 507. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Toraman, S. Evrenkaya, S. Senay, H. Karabulut, and C. Alhan Adjusting Oxygen Fraction to Avoid Hyperoxemia During Cardiopulmonary Bypass Asian Cardiovasc Thorac Ann, August 1, 2007; 15(4): 303 - 306. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. I. Ellman, J. S. Alvis, C. Tache-Leon, R. Singh, T. B. Reece, J. A. Kern, C. G. Tribble, and I. L. Kron Hyperoxic ventilation exacerbates lung reperfusion injury J. Thorac. Cardiovasc. Surg., November 1, 2005; 130(5): 1440 - 1440. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Baufreton, P. Allain, A. Chevailler, F. Etcharry-Bouyx, J. J. Corbeau, D. Legall, and J. L. de Brux Brain Injury and Neuropsychological Outcome After Coronary Artery Surgery Are Affected by Complement Activation Ann. Thorac. Surg., May 1, 2005; 79(5): 1597 - 1605. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Serviddio, N. Di Venosa, A. Federici, D. D'Agostino, T. Rollo, F. Prigigallo, E. Altomare, T. Fiore, and G. Vendemiale Brief hypoxia before normoxic reperfusion (postconditioning) protects the heart against ischemia-reperfusion injury by preventing mitochondria peroxyde production and glutathione depletion FASEB J, March 1, 2005; 19(3): 354 - 361. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Ngaage Off-pump coronary artery bypass grafting: the myth, the logic and the science Eur. J. Cardiothorac. Surg., October 1, 2003; 24(4): 557 - 570. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M. Matata and M. Galinanes Effect of Diabetes on Nitric Oxide Metabolism During Cardiac Surgery Diabetes, November 1, 2001; 50(11): 2603 - 2610. [Abstract] [Full Text] [PDF] |
||||
![]() |
G Matheis, M Scholz, A Simon, O. Dzemali, and A Moritz Leukocyte filtration in cardiac surgery: a review Perfusion, September 1, 2001; 16(5): 361 - 370. [Abstract] [PDF] |
||||
![]() |
Y. J. Gu, P. W. Boonstra, and W. van Oeveren Effect of normoxic cardiopulmonary bypass on leukocyte elastase release J. Thorac. Cardiovasc. Surg., May 1, 1999; 117(5): 1045 - 1046. [Full Text] |
||||
![]() |
K. Ihnken Reply J. Thorac. Cardiovasc. Surg., May 1, 1999; 117(5): 1046 - 1046. [Full Text] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |